宫颈癌治疗的新范式
尽管筛查和人乳头瘤病毒疫苗有效,宫颈癌仍是全球公共卫生负担,资源匮乏国家尤甚。世界卫生组织提出2030年消除宫颈癌目标。本文聚焦早期手术、局部晚期放化疗调整及复发转移系统治疗的近期与 ongoing 改进方向。
要点
- 世界卫生组织设有消除宫颈癌目标,各国需在2030年前达成相关指标。
- 早期宫颈癌治疗改进聚焦手术方式评估。
- 局部晚期宫颈癌关注放化疗方案调整,复发转移者关注系统治疗。
核心结论
- 宫颈癌治疗需在近期保持有效的同时改善结局,相关评估正在进行。
研究设计与样本
- 本文为综述,聚焦改善宫颈癌结局的近期与 ongoing 重点领域。
主要发现
- 筛查策略和预防性高危人乳头瘤病毒疫苗接种已实施,但宫颈癌仍是显著公共卫生负担。
- 负担在筛查和疫苗接种项目未充分发展的资源匮乏国家最为突出,工业化国家亦存在该病。
- 世界卫生组织积极聚焦消除宫颈癌,设有各国需在2030年前达成的客观指标。
- 接近消除宫颈癌需增加疫苗接种和筛查,治疗也需持续有效并改善结局。
- 评估包括早期患者手术、局部晚期患者放化疗调整及复发或转移患者系统治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite effective screening strategies and the development and implementation of prophylactic high-risk human papillomavirus vaccination, cervical cancer remains a significant public health burden. This burden is most pronounced in under-resourced countries without fully developed screening and vaccination programs, although the disease remains present worldwide, including in industrialized countries. To that end, the World Health Organization (WHO) has an active focus on the elimination of cervical cancer, with objective metrics to be achieved by countries by the year 2030. Although increased vaccination and screening will be needed to approach potential eradication of cervical cancer, as recognized by the WHO initiative, treatment will need to continue to not only be effective in the near term, but to improve outcomes as well. Accordingly, assessments to improve primary treatment options, including surgery for women with early-stage disease, modification of chemoradiation for those with locally advanced cervical cancer, and systemic therapy for those with recurrent or metastatic presentations, are ongoing. Accordingly, we highlight important areas of both recent and ongoing focus as they relate to improving cervical cancer outcomes.
引用
- Boitano TKL, Kako T, Leath CA, et al. New Paradigms in the Treatment of Cervical Cancer. Obstet Gynecol. 2023. PMID: 37826852. doi:10.1097/AOG.0000000000005413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。